The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats

European Journal of Pharmacology

Volumn 320, Issue 1, 1997, Pages 73-80

  Buritova, Jaroslava ^a   Chapman, Victoria ^a   Honoré, Prisca ^a   Besson, Jean Marie ^a  

^a INSERM   (France)

Author keywords

Bradykinin; c Fos; Carrageenan inflammation; Nociception; Spinal cord

Indexed keywords

BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CARRAGEENAN; ICATIBANT; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANKLE EDEMA; ARTICLE; CONTROLLED STUDY; EDEMA; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD;

ANIMALS; BRADYKININ; CARRAGEENAN; EDEMA; FOOT; HINDLIMB; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SPINAL CORD;

EID: 0031039328     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00872-2     Document Type: Article

References (55)

1. Bao, G., F. Qadri, B. Stauss, H. Stauss, P. Gohlke and T. Unger, 1991, Hoe 140, a new highly potent and long-acting bradykinin antagonist in conscious rats, Eur. J. Pharmacol. 200, 179.
2. Bathon, J.M. and D. Proud, 1991, Bradykinin antagonists, Annu. Rev. Pharmacol. Toxicol. 31, 129.
3. Beresford, I.J.M. and P.J. Birch, 1992, Antinociceptive activity of the bradykinin antagonist Hoe-140 in rat and mouse, Br. J. Pharmacol. 105, 135P.
4. Besson, J.M. and A. Chaouch, 1987, Peripheral and spinal mechanisms of nociception, Physiol. Rev. 67, 67.
5. Buritova, J., P. Honoré, V. Chapman and J.M. Besson, 1996a, Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and spinal c-Fos expression in the rat: synergistic mechanisms, Pain 64, 559.
6. Buritova, J., V. Chapman, P. Honoré and J.M. Besson, 1996b, Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal Fos expression in the rat, Brain Res. 715, 217.
7. Chapman, V. and A.H. Dickenson, 1992, The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat, Eur. J. Pharmacol. 219, 427.
8. 2 kinin receptors in formalin-induced nociceptive response in the mouse, Br. J. Pharmacol. 110, 193.
9. Damas, J. and G. Remacle-Volon, 1992, Influence of a long-acting bradykinin antagonist, Hoe 140, on some acute inflammatory reactions in the rat, Eur. J. Pharmacol. 211, 81.
10. Di Rosa, M., J.P. Giroud and D.A. Willoughby, 1971, Studies of the mediators of the acute inflammatory-response induced in rats in different sites by carrageenin and turpentine, J. Pathol. 104, 15.
11. Dray, A., 1994, Chemical activation and sensitization of nociceptors, in: Peripheral Neurons in Nociception: Physio-Pharmacological Aspects, eds. J.M. Besson, G. Guilbaud and H. Ollat (John Libbey Eurotext, Paris) p. 49.
12. Dray, A., 1995, Inflammatory mediators of pain, Br. J. Anaesth. 75, 125.
13. Dray, A. and M. Perkins, 1993, Bradykinin and inflammatory pain, Trends Neurosci. 16, 99.
14. Ferreira, S.H., 1972, Prostanglandins, aspirin-like drugs and analgesia, Nature 240, 200.
15. Ferreira, S.H. and B.B. Lorenzetti, 1995, Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception, Neuropharmacology 33, 1479.
16. Ferreira, S.H., S. Moncada and J.R. Vane, 1973, Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs, Br. J. Pharmacol. 49, 86.
17. Ferreira, S.H., B.B. Lorenzetti and S. Poole, 1993, Bradykinin initiates cytokine-mediated inflammatory hyperalgesia, Br. J. Pharmacol. 110, 1227.
18. Haley, J.E., A.H. Dickenson and M. Schachter, 1989, Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat, Neurosci. Lett. 97, 198.
19. Hargreaves, K., E.S. Troullos, R.A. Dionne, E.A. Schmidt, S.C. Schafer and J.L. Joris, 1988a, Bradykinin is increased during acute and chronic inflammation: therapeutic implications, Clin. Pharmacol. Ther. 44, 613.
20. Hargreaves, K., R. Dubner, C. Brown and J. Joris, 1988b, A new and sensitive methode for measuring thermal nociception in cutaneous hyperalgesia, Pain 32, 77.
21. Heapy, C.G., J.S. Shaw and S.C. Farmer, 1993, Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140, Br. J. Pharmacol. 108, 209.
22. Herdegen, T., K. Kovary, J. Leah and R. Bravo, 1991, Specific temporal and spatial distribution of JUN, FOS and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation, J. Comp. Neurol. 313, 178.
23. Hock, F.J., K. Wirth, U. Albus, W. Linz, H.J. Gerhards, G. Wiemer, S. Henke, G. Breipohl, W. König, J. Knolle and B.A. Schölkens, 1991, Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies, Br. J. Pharmacol. 102, 769.
24. Honoré, P., J. Buritova and J.M. Besson, 1995, Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin, Eur. J. Pharmacol. 272, 249.
25. Honoré, P., J. Buritova and J.M. Besson, 1996, Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat, Br. J. Pharmacol. 118, 671.
26. Hsu, S., L. Raine and H. Fanger, 1981, Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures, J. Histochem. Cytochem. 29, 577.
27. Hughes, P. and M. Dragunow, 1995, Induction of immediate-early genes and the control of neurotransmitter-regulated expression within the nervous system, Pharmacol. Rev. 47, 133.
28. Iadarola, M.J., L.S. Brady, G. Draisci and R. Dubner, 1988, Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioural parameters and opioid receptor binding, Pain 35, 313.
29. Jensen, K., C. Tuxen, U. Pedersen-Bjergaard, I. Jansen, L. Edvinsson and J. Olesen, 1990, Pain, wheal and flare in human forearm skin induced by bradykinin and 5-hydroxytryptamine, Peptides 11, 1133.
30. Joris, J., A. Costello, R. Dubner and K. Hargreaves, 1990, Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia, Pain 43, 95.
31. Khasar, S.G., F.J.-P. Miao and J.D. Levine, 1995, Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat, Neuroscience 69, 685.
32. Kirchhoff, C., S. Jung, P.W. Reeh and H.O. Handwerker, 1990, Carrageenan inflammation increases bradykinin sensitivity of rat cutaneous nociceptors, Neurosci. Lett. 111, 206.
33. Kocher, L., F. Anton, P.W. Reeh and H.O. Handwerker, 1987, The effect of carrageenin-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat, Pain 29, 363.
34. Lembeck, F., H. Popper and H. Juan, 1976, Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect, Naunyn-Schmiedeberg's Arch. Pharmacol. 294, 69.
35. Lembeck, F., T. Griesbacher, M. Eckhardt, S. Henke, G. Breipohl and J. Knolle, 1991, New, long-acting, potent bradykinin antagonist, Br. J. Pharmacol. 102, 297.
36. Levine, J.D., H.L. Fields and A.I. Basbaum, 1993, Peptides and the primary afferent nociceptor, J. Neurosci. 13, 2273.
37. Malmberg, A.B. and T.L. Yaksh, 1992, Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat, J. Pharmacol. Exp. Ther. 263, 136.
38. Malmberg, A.B. and T.L. Yaksh, 1994, Antinociception produced by spinal delivery of S and R enantiomers of flurbiprofen in the formalin test in rats, Eur. J. Pharmacol. 256, 205.
39. Martin, H.A., A.I. Basbaum, G.C. Kwiat, E.J. Goetzl and J.D. Levine, 1987, Leukotriene and prostaglandin sensitization of cutaneous high treshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs, Neuroscience 22, 651.
40. Menétrey, D., J. De Pommery, K.G. Baimbridge and M. Thomasset, 1992, Calbindin-D28K (CaBP28k)-like immunoreactivity in ascending projections. I. Trigeminal nucleus caudalis and dorsal vagal complex projections, Eur. J. Neurosci. 4, 61.
41. Molander, C. and G. Grant, 1985, Cutaneous projection from the rat hindlimb foot to substantia gelatinosa of the spinal cord studied by transganglionic transport of WGA-HRP conjugate, J. Comp. Neurol. 237, 476.
42. Molander, C. and G. Grant, 1986, Laminar distribution and somatotopic organization of primary afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport of horseradish peroxidase in the rat, Neuroscience 19, 297.
43. Molander, C., Q. Xu and G. Grant, 1984, The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord, J. Comp. Neurol. 230, 133.
44. Morgan, J.I. and T. Curran, 1991, Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci. 14, 421.
45. Munglani, R. and S.P. Hunt, 1995, Molecular biology of pain, Br. J. Anaesth. 75, 186.
46. 8)-BK and HOE 140, in two models, Pain 53, 191.
47. Rang, H.P., S. Bevan and A. Dray, 1991, Chemical activation of nociceptive peripheral neurones, Br. Med. Bull. 47, 534.
48. Schremmer-Danninger, E., P. Heinz-Erian, E. Töpfer-Petersen and A.A. Roscher, 1995, Autoradiographic localization and characterization of bradykinin receptors in human skin, Eur. J. Pharmacol. 283, 207.
49. Steranka, L.R. and Burch, R.M., 1991, Bradykinin antagonists in pain and inflammation, in: Bradykinin Antagonists, ed. R.M. Burch (Marcel Dekker, New York, NY) p. 191.
50. Steranka, L.R., D.C. Manning, C.J. Dehass, J.W. Ferkany, S.A. Borosky, J.R. Connor, R.J. Vavrek, J.M. Stewart and S.H. Snyder, 1988, Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions, Proc. Natl. Acad. Sci. USA 85, 3245.
51. Taiwo, Y.O., P.M. Heller and J.D. Levine, 1990, Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia, Neuroscience 39, 523.
52. Willis, W.D. and R.E. Coggeshall, 1991, Structure of the dorsal horn, in: Sensory Mechanisms of the Spinal Cord (Plenum Press, New York, NY) p. 79.
53. Winter, C.A., E.A. Risley and G.W. Nuss, 1962, Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Proc. Soc. Exp. Biol. Med. 111, 544.
54. Wirth, K., F.J. Hock, U. Albus, W. Linz, H.G. Alpermann, H. Anagnostopoulos, S.T. Henke, G. Breipohl, W. König, J. Knolle and B.A. Schölkens, 1991, Hoe 140 a new potent and long acting bradykinin antagonist: in vivo studies, Br. J. Pharmacol. 102, 774.
55. Zimmermann, M., 1983, Ethical guidelines for investigations of experimental pain in conscious animals, Pain 16, 109.